Propulsid Problems

NPR's Joanne Silberner reports that yesterday, Johnson & Johnson the maker of the prescription heartburn drug Propulsid said it would stop marketing the product in the United States after reports of serious cardiovascular side effects, including 80 deaths.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: